Venture Capital & Emerging Companies

Read an analysis of the differences between public benefit corporations and traditional corporations and issues for founders of mission-driven business to consider when deciding on a corporate structure.

Public and private life science companies have multiple options available for capital-raising. Here are a few to be considered.

This edition of MintzTech Connect covers the patentability of blockchain and cryptocurrency, SEC Rule 148, a Delaware Supreme Court ruling on the advance waiver of appraisal rights, and Miyoko’s Creamery.

This edition covers the patentability of blockchain and cryptocurrency, SEC Rule 148, a Delaware Supreme Court ruling on the advance waiver of appraisal rights, and Miyoko’s Creamery.

This alert discusses the Delaware Supreme Court’s decision in Manti Holdings v. Authentix Acquisition Co. that upheld the enforceability of an advance waiver of statutory appraisal rights by common stockholders.

Venture capital investing continues to thrive across all sectors. During the first half of 2021, the Mintz team advised more than 65 emerging companies and investors in transactions in all facets of the life sciences, technology, and energy and sustainability industries.

This issue of MintzTech Connect covers issues related to ransomware and mandatory vaccinations for people returning to private offices, plus spotlights on EcoCart and Stavvy.

Read about EcoCart, a company that provides an e-commerce plugin for merchants to offer carbon-neutral orders and a Chrome extension for shoppers looking to lower their carbon footprint.

Read about Stavvy, an innovative fintech company that provides a collaborative platform for lenders, title agents, attorneys, notaries, settlement agents, borrowers, and others involved in real estate transactions.

This alert covers the New York City Economic Development Corporation’s RFP seeking proposals for projects supporting new ventures and technology development in NYC’s life sciences community.

Please join your favorite SPAC corporate attorneys, Tom Burton, Sahir Surmeli, and Jeff Schultz as they set the record straight on SPACs’ apparent boom and bust, heavily reported on in the media.